Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Madhu Kumar is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/05/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 18.96% | Madhu Kumar72% | → $169 | Initiates | → Buy | Get Alert |
| 01/26/2024 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 102.02% | Madhu Kumar72% | $5 → $6 | Maintains | Neutral | Get Alert |
| 01/25/2024 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 102.02% | Madhu Kumar72% | $5 → $6 | Maintains | Neutral | Get Alert |
| 12/07/2023 | INFA | Buy Now | Informatica | $18.20 | 42.86% | Madhu Kumar72% | $23 → $26 | Maintains | Neutral | Get Alert |
| 11/10/2023 | UTZ | Buy Now | Utz Brands | $13.55 | 25.46% | Madhu Kumar72% | $19 → $17 | Maintains | Neutral | Get Alert |
| 09/25/2023 | ALEC | Buy Now | Alector | $1.33 | 200.75% | Madhu Kumar72% | → $4 | Initiates | → Sell | Get Alert |
| 09/25/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 68.35% | Madhu Kumar72% | → $5 | Initiates | → Neutral | Get Alert |
| 08/04/2023 | INFA | Buy Now | Informatica | $18.20 | 15.38% | Madhu Kumar72% | $19 → $21 | Maintains | Neutral | Get Alert |
| 08/03/2023 | INFA | Buy Now | Informatica | $18.20 | 15.38% | Madhu Kumar72% | $19 → $21 | Maintains | Neutral | Get Alert |
| 05/23/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Madhu Kumar72% | $31 → $30 | Maintains | Neutral | Get Alert |
| 05/22/2023 | KRYS | Buy Now | Krystal Biotech | $189.18 | -18.07% | Madhu Kumar72% | $135 → $155 | Maintains | Buy | Get Alert |
| 05/07/2023 | KRYS | Buy Now | Krystal Biotech | $189.18 | -28.64% | Madhu Kumar72% | → $135 | Maintains | Buy | Get Alert |
| 05/05/2023 | INFA | Buy Now | Informatica | $18.20 | 597.8% | Madhu Kumar72% | $113 → $127 | Maintains | Neutral | Get Alert |
| 05/05/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 1.01% | Madhu Kumar72% | $9 → $3 | Maintains | Neutral | Get Alert |
| 05/05/2023 | CYTK | Buy Now | Cytokinetics | $43.45 | 21.98% | Madhu Kumar72% | $48 → $53 | Maintains | Buy | Get Alert |
| 05/04/2023 | INFA | Buy Now | Informatica | $18.20 | 4.4% | Madhu Kumar72% | $22 → $19 | Maintains | Neutral | Get Alert |
| 05/04/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 1.01% | Madhu Kumar72% | $9 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 05/04/2023 | DSGN | Buy Now | Design Therapeutics | $4.83 | — | Madhu Kumar72% | — | Upgrade | Sell → Neutral | Get Alert |
| 05/03/2023 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 371.88% | Madhu Kumar72% | $65 → $73 | Maintains | Buy | Get Alert |
| 04/14/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 459.3% | Madhu Kumar72% | $124 → $141 | Maintains | Buy | Get Alert |
| 03/13/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 203.03% | Madhu Kumar72% | $17 → $9 | Maintains | Buy | Get Alert |
| 03/03/2023 | UTZ | Buy Now | Utz Brands | $13.55 | 47.6% | Madhu Kumar72% | $18 → $20 | Maintains | Neutral | Get Alert |
| 03/03/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 49.22% | Madhu Kumar72% | $190 → $212 | Maintains | Buy | Get Alert |
| 03/02/2023 | CYTK | Buy Now | Cytokinetics | $43.45 | 10.47% | Madhu Kumar72% | $56 → $48 | Maintains | Buy | Get Alert |
| 03/01/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.12 | 159.15% | Madhu Kumar72% | $39 → $34 | Maintains | Buy | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Madhu Kumar72% | $117 → $185 | Maintains | Buy | Get Alert |
| 02/28/2023 | KRYS | Buy Now | Krystal Biotech | $189.18 | -34.45% | Madhu Kumar72% | $79 → $124 | Upgrade | Neutral → Buy | Get Alert |
| 02/24/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Madhu Kumar72% | $115 → $117 | Maintains | Buy | Get Alert |
| 02/22/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Madhu Kumar72% | $28 → $31 | Maintains | Neutral | Get Alert |
| 01/19/2023 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 472.39% | Madhu Kumar72% | $11 → $17 | Maintains | Buy | Get Alert |
| 01/17/2023 | CYTK | Buy Now | Cytokinetics | $43.45 | 28.88% | Madhu Kumar72% | $47 → $56 | Maintains | Buy | Get Alert |
| 12/15/2022 | CYTK | Buy Now | Cytokinetics | $43.45 | 8.17% | Madhu Kumar72% | $55 → $47 | Maintains | Buy | Get Alert |
| 12/12/2022 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.12 | 197.26% | Madhu Kumar72% | $35 → $39 | Maintains | Buy | Get Alert |
| 12/09/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | 67.61% | Madhu Kumar72% | $20 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 12/09/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | 67.61% | Madhu Kumar72% | $20 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 12/09/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 33.74% | Madhu Kumar72% | $192 → $190 | Upgrade | Neutral → Buy | Get Alert |
| 11/28/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Madhu Kumar72% | $86 → $115 | Maintains | Buy | Get Alert |
| 11/15/2022 | FULC | Buy Now | Fulcrum Therapeutics | $2.97 | 270.37% | Madhu Kumar72% | → $11 | Initiates | → Buy | Get Alert |
| 11/10/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 35.14% | Madhu Kumar72% | $170 → $192 | Maintains | Neutral | Get Alert |
| 11/10/2022 | ARCT | Buy Now | Arcturus Therapeutics | $13.40 | 4.48% | Madhu Kumar72% | $8 → $14 | Maintains | Sell | Get Alert |
| 11/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Madhu Kumar72% | $76 → $86 | Maintains | Buy | Get Alert |
| 11/07/2022 | KRYS | Buy Now | Krystal Biotech | $189.18 | -58.24% | Madhu Kumar72% | $74 → $79 | Maintains | Neutral | Get Alert |
| 11/04/2022 | DVAX | Buy Now | Dynavax Technologies | $13.69 | 53.4% | Madhu Kumar72% | $24 → $21 | Maintains | Buy | Get Alert |
| 10/28/2022 | CINC | Buy Now | CinCor Pharma | — | — | Madhu Kumar72% | → $67 | Initiates | → Buy | Get Alert |
| 09/29/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 19.66% | Madhu Kumar72% | $148 → $170 | Maintains | Neutral | Get Alert |
| 09/21/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 4.17% | Madhu Kumar72% | $192 → $148 | Maintains | Neutral | Get Alert |
| 09/21/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Madhu Kumar72% | $24 → $28 | Maintains | Neutral | Get Alert |
| 08/25/2022 | KRYS | Buy Now | Krystal Biotech | $189.18 | -60.88% | Madhu Kumar72% | → $74 | Downgrade | Buy → Neutral | Get Alert |
| 08/25/2022 | EWTX | Buy Now | Edgewise Therapeutics | $24.59 | -79.67% | Madhu Kumar72% | → $5 | Downgrade | Neutral → Sell | Get Alert |
| 08/25/2022 | MGTA | Buy Now | Magenta Therapeutics | — | — | Madhu Kumar72% | → $32 | Downgrade | Buy → Neutral | Get Alert |
| 08/09/2022 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.12 | 166.77% | Madhu Kumar72% | $40 → $35 | Maintains | Buy | Get Alert |
| 08/09/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 304.6% | Madhu Kumar72% | $91 → $102 | Maintains | Buy | Get Alert |
| 08/08/2022 | KRYS | Buy Now | Krystal Biotech | $189.18 | -60.88% | Madhu Kumar72% | $78 → $74 | Maintains | Buy | Get Alert |
| 08/08/2022 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 320.17% | Madhu Kumar72% | $58 → $65 | Maintains | Buy | Get Alert |
| 08/04/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | Madhu Kumar72% | $164 → $144 | Maintains | Buy | Get Alert |
| 07/28/2022 | MYOV | Buy Now | Myovant Sciences | — | — | Madhu Kumar72% | $9 → $10 | Maintains | Neutral | Get Alert |
| 07/01/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | 402.82% | Madhu Kumar72% | $64 → $18 | Maintains | Buy | Get Alert |
| 05/24/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Madhu Kumar72% | $93 → $73 | Maintains | Buy | Get Alert |
| 05/24/2022 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.12 | 204.88% | Madhu Kumar72% | $51 → $40 | Maintains | Buy | Get Alert |
| 05/24/2022 | TCDA | Buy Now | Tricida | — | — | Madhu Kumar72% | $22 → $16 | Maintains | Buy | Get Alert |
| 05/24/2022 | MGTA | Buy Now | Magenta Therapeutics | — | — | Madhu Kumar72% | $48 → $32 | Maintains | Buy | Get Alert |
| 05/24/2022 | KRYS | Buy Now | Krystal Biotech | $189.18 | -58.77% | Madhu Kumar72% | $91 → $78 | Maintains | Buy | Get Alert |
| 05/24/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | 1687.81% | Madhu Kumar72% | $79 → $64 | Maintains | Buy | Get Alert |
| 05/24/2022 | EDIT | Buy Now | Editas Medicine | $1.41 | 467.42% | Madhu Kumar72% | $10 → $8 | Maintains | Sell | Get Alert |
| 05/24/2022 | EWTX | Buy Now | Edgewise Therapeutics | $24.59 | -79.67% | Madhu Kumar72% | $8 → $5 | Maintains | Neutral | Get Alert |
| 05/24/2022 | DSGN | Buy Now | Design Therapeutics | $4.83 | 24.22% | Madhu Kumar72% | $8 → $6 | Maintains | Sell | Get Alert |
| 05/24/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Madhu Kumar72% | $28 → $20 | Maintains | Neutral | Get Alert |
| 05/24/2022 | ARVN | Buy Now | Arvinas | $8.70 | 922.99% | Madhu Kumar72% | $111 → $89 | Maintains | Buy | Get Alert |
| 05/24/2022 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 326.63% | Madhu Kumar72% | $90 → $66 | Maintains | Buy | Get Alert |
| 05/24/2022 | ARCT | Buy Now | Arcturus Therapeutics | $13.40 | -40.3% | Madhu Kumar72% | $14 → $8 | Maintains | Sell | Get Alert |
| 05/24/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 233.2% | Madhu Kumar72% | $94 → $84 | Maintains | Buy | Get Alert |
| 05/24/2022 | ALEC | Buy Now | Alector | $1.33 | 351.13% | Madhu Kumar72% | $9 → $6 | Maintains | Sell | Get Alert |
| 05/12/2022 | EWTX | Buy Now | Edgewise Therapeutics | $24.59 | -67.47% | Madhu Kumar72% | $11 → $8 | Maintains | Neutral | Get Alert |
| 05/11/2022 | TCDA | Buy Now | Tricida | — | — | Madhu Kumar72% | $25 → $22 | Maintains | Buy | Get Alert |
| 05/11/2022 | MYOV | Buy Now | Myovant Sciences | — | — | Madhu Kumar72% | $19 → $11 | Maintains | Neutral | Get Alert |
| 05/11/2022 | ARCT | Buy Now | Arcturus Therapeutics | $13.40 | 4.48% | Madhu Kumar72% | $16 → $14 | Maintains | Sell | Get Alert |
| 04/13/2022 | TCDA | Buy Now | Tricida | — | — | Madhu Kumar72% | → $25 | Initiates | → Buy | Get Alert |
| 04/13/2022 | ALEC | Buy Now | Alector | $1.33 | 576.69% | Madhu Kumar72% | → $9 | Initiates | → Sell | Get Alert |
| 04/06/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $142.07 | 37.96% | Madhu Kumar72% | $202 → $196 | Downgrade | Buy → Neutral | Get Alert |
| 03/24/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Madhu Kumar72% | $34 → $91 | Upgrade | Neutral → Buy | Get Alert |
| 03/07/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 241.13% | Madhu Kumar72% | $102 → $86 | Maintains | Buy | Get Alert |
| 03/01/2022 | KRYS | Buy Now | Krystal Biotech | $189.18 | -50.84% | Madhu Kumar72% | $125 → $93 | Maintains | Buy | Get Alert |
| 03/01/2022 | ARVN | Buy Now | Arvinas | $8.70 | 1164.37% | Madhu Kumar72% | $157 → $110 | Maintains | Buy | Get Alert |
| 02/15/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Madhu Kumar72% | → $27 | Initiates | → Neutral | Get Alert |
| 02/15/2022 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.12 | 182.01% | Madhu Kumar72% | → $37 | Initiates | → Buy | Get Alert |
| 01/19/2022 | PASG | Buy Now | Passage Bio | $0.45 | 1233.33% | Madhu Kumar72% | $29 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 01/19/2022 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | — | Madhu Kumar72% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/19/2022 | DSGN | Buy Now | Design Therapeutics | $4.83 | 107.04% | Madhu Kumar72% | → $10 | Initiates | → Sell | Get Alert |
| 01/19/2022 | ARVN | Buy Now | Arvinas | $8.70 | 1704.6% | Madhu Kumar72% | → $157 | Initiates | → Buy | Get Alert |
| 01/06/2022 | MGTA | Buy Now | Magenta Therapeutics | — | — | Madhu Kumar72% | $112 → $128 | Upgrade | Neutral → Buy | Get Alert |
| 11/29/2021 | KRYS | Buy Now | Krystal Biotech | $189.18 | -33.93% | Madhu Kumar72% | $85 → $125 | Maintains | Buy | Get Alert |
| 11/19/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | Madhu Kumar72% | → $168 | Upgrade | Neutral → Buy | Get Alert |
| 08/27/2021 | APLT | Buy Now | Applied Therapeutics | $0.53 | 1788.93% | Madhu Kumar72% | → $10 | Downgrade | Neutral → Sell | Get Alert |
| 08/24/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | Madhu Kumar72% | $96 → $107 | Maintains | Neutral | Get Alert |
| 08/11/2021 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Madhu Kumar72% | $36 → $25 | Downgrade | Buy → Neutral | Get Alert |
| 08/11/2021 | ARCT | Buy Now | Arcturus Therapeutics | $13.40 | 116.42% | Madhu Kumar72% | → $29 | Downgrade | Neutral → Sell | Get Alert |
| 08/09/2021 | KRYS | Buy Now | Krystal Biotech | $189.18 | -54.01% | Madhu Kumar72% | $90 → $87 | Maintains | Buy | Get Alert |
| 08/06/2021 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Madhu Kumar72% | $48 → $36 | Maintains | Buy | Get Alert |
| 08/06/2021 | DVAX | Buy Now | Dynavax Technologies | $13.69 | 38.79% | Madhu Kumar72% | → $190 | Initiates | → Buy | Get Alert |
| 08/03/2021 | ALEC | Buy Now | Alector | $1.33 | 2381.2% | Madhu Kumar72% | $29 → $33 | Maintains | Buy | Get Alert |
| 07/20/2021 | KRYS | Buy Now | Krystal Biotech | $189.18 | -52.43% | Madhu Kumar72% | $73 → $90 | Upgrade | Neutral → Buy | Get Alert |
| 06/23/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 813.98% | Madhu Kumar72% | $60 → $85 | Maintains | Neutral | Get Alert |
| 05/10/2021 | KRYS | Buy Now | Krystal Biotech | $189.18 | -61.41% | Madhu Kumar72% | $85 → $73 | Maintains | Neutral | Get Alert |
| 04/16/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | 2609.65% | Madhu Kumar72% | → $97 | Initiates | → Buy | Get Alert |
| 04/16/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 415.67% | Madhu Kumar72% | → $130 | Initiates | → Buy | Get Alert |
| 04/16/2021 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Madhu Kumar72% | → $48 | Initiates | → Buy | Get Alert |
| 04/16/2021 | EDIT | Buy Now | Editas Medicine | $1.41 | 1318.54% | Madhu Kumar72% | → $20 | Initiates | → Sell | Get Alert |
| 03/16/2021 | CLLS | Buy Now | Cellectis | $1.29 | 2923.49% | Madhu Kumar72% | $23 → $39 | Upgrade | Neutral → Outperform | Get Alert |
| 01/20/2021 | GRTS | Buy Now | Gritstone Bio | — | — | Madhu Kumar72% | → $8 | Downgrade | Outperform → Underperform | Get Alert |
| 12/29/2020 | ARCT | Buy Now | Arcturus Therapeutics | $13.40 | 414.93% | Madhu Kumar72% | $79 → $69 | Downgrade | Outperform → Neutral | Get Alert |
| 12/22/2020 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | — | Madhu Kumar72% | — | Downgrade | Outperform → Neutral | Get Alert |
| 11/03/2020 | EDIT | Buy Now | Editas Medicine | $1.41 | 892.98% | Madhu Kumar72% | → $14 | Initiates | → Underperform | Get Alert |
| 10/15/2020 | CLLS | Buy Now | Cellectis | $1.29 | — | Madhu Kumar72% | — | Downgrade | Outperform → Neutral | Get Alert |
| 08/13/2020 | CBMG | Buy Now | Cellular Biomedicine Gr | — | — | Madhu Kumar72% | → $19 | Downgrade | Outperform → Neutral | Get Alert |
| 07/31/2020 | QURE | Buy Now | uniQure | $13.99 | 307.43% | Madhu Kumar72% | $58 → $57 | Upgrade | Neutral → Outperform | Get Alert |
| 07/24/2020 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | — | Madhu Kumar72% | — | Downgrade | Outperform → Neutral | Get Alert |
| 07/13/2020 | CBMG | Buy Now | Cellular Biomedicine Gr | — | — | Madhu Kumar72% | $19 → $28 | Upgrade | Neutral → Outperform | Get Alert |
| 07/07/2020 | CLLS | Buy Now | Cellectis | $1.29 | 1528.03% | Madhu Kumar72% | $28 → $21 | Maintains | Outperform | Get Alert |
| 06/25/2020 | QURE | Buy Now | uniQure | $13.99 | 314.58% | Madhu Kumar72% | → $58 | Downgrade | Outperform → Neutral | Get Alert |
| 04/21/2020 | APRE | Buy Now | Aprea Therapeutics | $2.40 | 1775% | Madhu Kumar72% | → $900 | Initiates | → Outperform | Get Alert |
| 03/27/2020 | VIR | Buy Now | Vir Biotechnology | $6.95 | 187.77% | Madhu Kumar72% | $17 → $20 | Maintains | Underperform | Get Alert |
| 03/27/2020 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 20.85% | Madhu Kumar72% | $8 → $4 | Maintains | Outperform | Get Alert |
| 03/13/2020 | PIRS | Buy Now | Pieris Pharmaceuticals | — | — | Madhu Kumar72% | → $400 | Upgrade | Neutral → Outperform | Get Alert |
| 03/13/2020 | AKTX | Buy Now | Akari Therapeutics | $1.30 | 284.62% | Madhu Kumar72% | $140 → $100 | Maintains | Buy | Get Alert |
| 03/12/2020 | SRRK | Buy Now | Scholar Rock Holding | $33.97 | 3.03% | Madhu Kumar72% | → $35 | Initiates | → Outperform | Get Alert |
| 02/20/2020 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 141.69% | Madhu Kumar72% | → $8 | Initiates | → Outperform | Get Alert |
| 02/11/2020 | ARCT | Buy Now | Arcturus Therapeutics | $13.40 | 79.1% | Madhu Kumar72% | → $24 | Initiates | → Outperform | Get Alert |
| 02/11/2020 | LPTX | Buy Now | Leap Therapeutics | $0.43 | 1284.08% | Madhu Kumar72% | → $60 | Initiates | → Outperform | Get Alert |
| 01/09/2020 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Madhu Kumar72% | $24 → $30 | Maintains | Buy | Get Alert |
| 01/09/2020 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 81.27% | Madhu Kumar72% | $3 → $6 | Maintains | Buy | Get Alert |
| 12/30/2019 | SBPH | Buy Now | Spring Bank | — | — | Madhu Kumar72% | → $2 | Downgrade | Buy → Neutral | Get Alert |
| 12/12/2019 | MGEN | Buy Now | Miragen Therapeutics | — | — | Madhu Kumar72% | $75 → $15 | Downgrade | Outperform → Neutral | Get Alert |
| 11/14/2019 | VIR | Buy Now | Vir Biotechnology | $6.95 | 144.6% | Madhu Kumar72% | → $17 | Initiates | → Neutral | Get Alert |
| 11/13/2019 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 281.38% | Madhu Kumar72% | $46 → $59 | Maintains | Buy | Get Alert |
| 11/12/2019 | CBMG | Buy Now | Cellular Biomedicine Gr | — | — | Madhu Kumar72% | $26 → $19 | Downgrade | Outperform → Neutral | Get Alert |
| 09/24/2019 | EYPT | Buy Now | EyePoint Pharmaceuticals | $6.45 | -37.98% | Madhu Kumar72% | $57.5 → $40 | Maintains | Buy | Get Alert |
| 09/24/2019 | KRYS | Buy Now | Krystal Biotech | $189.18 | -68.28% | Madhu Kumar72% | → $60 | Initiates | → Neutral | Get Alert |
| 08/19/2019 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 197.35% | Madhu Kumar72% | $32 → $46 | Maintains | Buy | Get Alert |
| 08/05/2019 | SBPH | Buy Now | Spring Bank | — | — | Madhu Kumar72% | $24 → $16 | Maintains | Buy | Get Alert |
| 07/30/2019 | PIRS | Buy Now | Pieris Pharmaceuticals | — | — | Madhu Kumar72% | → $400 | Downgrade | Outperform → Neutral | Get Alert |
| 07/26/2019 | GRTS | Buy Now | Gritstone Bio | — | — | Madhu Kumar72% | → $17 | Initiates | → Outperform | Get Alert |
| 07/09/2019 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 147.31% | Madhu Kumar72% | → $23 | Initiates | → Outperform | Get Alert |
| 05/14/2019 | PIRS | Buy Now | Pieris Pharmaceuticals | — | — | Madhu Kumar72% | → $400 | Initiates | → Outperform | Get Alert |
| 03/29/2019 | QURE | Buy Now | uniQure | $13.99 | 507.58% | Madhu Kumar72% | → $85 | Initiates | → Outperform | Get Alert |
| 02/07/2019 | CBMG | Buy Now | Cellular Biomedicine Gr | — | — | Madhu Kumar72% | → $26 | Initiates | → Outperform | Get Alert |
| 11/07/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Madhu Kumar72% | $68 → $71 | Upgrade | Neutral → Buy | Get Alert |
| 11/06/2018 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Madhu Kumar72% | $13.5 → $21 | Upgrade | Neutral → Buy | Get Alert |
| 10/22/2018 | ARVN | Buy Now | Arvinas | $8.70 | 95.4% | Madhu Kumar72% | → $17 | Initiates | → Neutral | Get Alert |
| 10/16/2018 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 171.9% | Madhu Kumar72% | $11.5 → $9 | Upgrade | Neutral → Buy | Get Alert |
| 10/16/2018 | EYPT | Buy Now | EyePoint Pharmaceuticals | $6.45 | -6.98% | Madhu Kumar72% | $50 → $60 | Maintains | Buy | Get Alert |
| 10/08/2018 | ASMB | Buy Now | Assembly Biosciences | $11.51 | 264.9% | Madhu Kumar72% | $504 → $504 | Upgrade | Neutral → Buy | Get Alert |
| 09/20/2018 | TOCA | Buy Now | Tocagen | — | — | Madhu Kumar72% | $225 → $330 | Maintains | Buy | Get Alert |
| 09/17/2018 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Madhu Kumar72% | $10 → $13.5 | Maintains | Neutral | Get Alert |
| 09/13/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 58.67% | Madhu Kumar72% | $27 → $40 | Maintains | Buy | Get Alert |
| 09/06/2018 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | — | Madhu Kumar72% | — | Upgrade | Neutral → Buy | Get Alert |
| 08/28/2018 | TTPH | Buy Now | Tetraphase Pharmaceutical | — | — | Madhu Kumar72% | $120 → $140 | Maintains | Buy | Get Alert |
| 08/24/2018 | IMMU | Buy Now | Immunomedics | — | — | Madhu Kumar72% | $53 → $55 | Maintains | Buy | Get Alert |
| 08/15/2018 | CMTA | Buy Now | Clementia Pharmaceuticals | — | — | Madhu Kumar72% | $25 → $16 | Maintains | Buy | Get Alert |
| 08/13/2018 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 247.43% | Madhu Kumar72% | $9 → $11.5 | Maintains | Neutral | Get Alert |
| 08/13/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $253.44 | -9.25% | Madhu Kumar72% | $210 → $230 | Maintains | Buy | Get Alert |
| 08/08/2018 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | 16.35% | Madhu Kumar72% | $12 → $18 | Maintains | Neutral | Get Alert |
| 07/30/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | — | Madhu Kumar72% | — | Upgrade | Neutral → Buy | Get Alert |
| 07/06/2018 | RGLS | Buy Now | Regulus Therapeutics | $1.40 | -64.29% | Madhu Kumar72% | $120 → $60 | Maintains | Neutral | Get Alert |
| 07/06/2018 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | — | Madhu Kumar72% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/28/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | Madhu Kumar72% | → $74 | Initiates | → Neutral | Get Alert |
| 06/19/2018 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Madhu Kumar72% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/16/2018 | TOCA | Buy Now | Tocagen | — | — | Madhu Kumar72% | → $225 | Initiates | → Buy | Get Alert |
| 05/15/2018 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | — | Madhu Kumar72% | — | Upgrade | Neutral → Buy | Get Alert |
| 05/11/2018 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | 570.43% | Madhu Kumar72% | $22 → $24 | Maintains | Buy | Get Alert |
| 05/09/2018 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Madhu Kumar72% | $52 → $43 | Maintains | Buy | Get Alert |
| 05/08/2018 | ASMB | Buy Now | Assembly Biosciences | $11.51 | 264.9% | Madhu Kumar72% | $540 → $504 | Maintains | Neutral | Get Alert |
| 04/12/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | — | Madhu Kumar72% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/10/2018 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | — | Madhu Kumar72% | — | Upgrade | Neutral → Buy | Get Alert |
| 03/28/2018 | RGLS | Buy Now | Regulus Therapeutics | $1.40 | -28.57% | Madhu Kumar72% | → $120 | Initiates | → Neutral | Get Alert |
| 03/28/2018 | CMTA | Buy Now | Clementia Pharmaceuticals | — | — | Madhu Kumar72% | → $25 | Initiates | → Buy | Get Alert |
| 03/28/2018 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Madhu Kumar72% | → $10 | Initiates | → Neutral | Get Alert |
| 02/23/2018 | IOVA | Buy Now | Iovance Biotherapeutics | $3.58 | — | Madhu Kumar72% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/16/2018 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Madhu Kumar72% | → $43 | Initiates | → Buy | Get Alert |
| 02/12/2018 | TTPH | Buy Now | Tetraphase Pharmaceutical | — | — | Madhu Kumar72% | → $220 | Initiates | → Buy | Get Alert |
| 02/12/2018 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | -74.14% | Madhu Kumar72% | $3 → $4 | Maintains | Neutral | Get Alert |
| 02/09/2018 | CBIO | Buy Now | Catalyst Biosciences | — | — | Madhu Kumar72% | $150 → $1125 | Maintains | Buy | Get Alert |
| 02/08/2018 | ACHN | Buy Now | Achillion Pharmaceuticals | — | — | Madhu Kumar72% | → $3.5 | Initiates | → Neutral | Get Alert |
| 02/08/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $25.21 | 7.1% | Madhu Kumar72% | → $27 | Initiates | → Buy | Get Alert |
| 02/08/2018 | IFRX | Buy Now | InflaRx | $1.24 | 3125.81% | Madhu Kumar72% | → $40 | Initiates | → Buy | Get Alert |
| 02/08/2018 | AKTX | Buy Now | Akari Therapeutics | $1.30 | 130.77% | Madhu Kumar72% | → $60 | Initiates | → Neutral | Get Alert |
| 01/05/2018 | MGEN | Buy Now | Miragen Therapeutics | — | — | Madhu Kumar72% | → $232.5 | Initiates | → Buy | Get Alert |
| 01/05/2018 | SNDX | Buy Now | Syndax Pharmaceuticals | $13.12 | 204.88% | Madhu Kumar72% | → $40 | Initiates | → Buy | Get Alert |
| 01/05/2018 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 202.11% | Madhu Kumar72% | → $10 | Initiates | → Buy | Get Alert |
| 01/05/2018 | ARWR | Buy Now | Arrowhead Pharma | $15.47 | -80.61% | Madhu Kumar72% | → $3 | Initiates | → Neutral | Get Alert |
| 01/05/2018 | ASMB | Buy Now | Assembly Biosciences | $11.51 | 204.08% | Madhu Kumar72% | → $420 | Initiates | → Neutral | Get Alert |
| 12/01/2017 | TGTX | Buy Now | TG Therapeutics | $42.12 | -48.96% | Madhu Kumar72% | → $21.5 | Reinstates | → Buy | Get Alert |
| 11/08/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $253.44 | -13.19% | Madhu Kumar72% | $240 → $220 | Maintains | Buy | Get Alert |
| 11/06/2017 | SBPH | Buy Now | Spring Bank | — | — | Madhu Kumar72% | → $30 | Initiates | → Buy | Get Alert |
| 08/29/2017 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | — | Madhu Kumar72% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/02/2017 | RGLS | Buy Now | Regulus Therapeutics | $1.40 | — | Madhu Kumar72% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/02/2017 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 115.05% | Madhu Kumar72% | $19 → $20 | Maintains | Buy | Get Alert |
| 06/12/2017 | CBIO | Buy Now | Catalyst Biosciences | — | — | Madhu Kumar72% | → $150 | Initiates | → Buy | Get Alert |
| 05/31/2017 | AKTX | Buy Now | Akari Therapeutics | $1.30 | — | Madhu Kumar72% | — | Upgrade | Sell → Neutral | Get Alert |
| 04/17/2017 | AKTX | Buy Now | Akari Therapeutics | $1.30 | 400% | Madhu Kumar72% | $100 → $130 | Reiterates | → Sell | Get Alert |
| 04/04/2017 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 81.27% | Madhu Kumar72% | $3 → $6 | Upgrade | Neutral → Buy | Get Alert |
| 03/28/2017 | CRSP | Buy Now | CRISPR Therapeutics | $41.55 | -43.44% | Madhu Kumar72% | → $23.5 | Initiates | → Buy | Get Alert |
| 03/28/2017 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 104.3% | Madhu Kumar72% | → $19 | Initiates | → Buy | Get Alert |
| 03/28/2017 | EDIT | Buy Now | Editas Medicine | $1.41 | 4510.26% | Madhu Kumar72% | → $65 | Initiates | → Buy | Get Alert |
| 12/13/2016 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | -9.37% | Madhu Kumar72% | $4 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 11/30/2016 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | 20.85% | Madhu Kumar72% | $3 → $4 | Upgrade | Neutral → Buy | Get Alert |
| 10/14/2016 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | — | Madhu Kumar72% | — | Upgrade | Sell → Neutral | Get Alert |
| 07/11/2016 | AKTX | Buy Now | Akari Therapeutics | $1.30 | 284.62% | Madhu Kumar72% | → $100 | Initiates | → Sell | Get Alert |
| 07/08/2016 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | — | Madhu Kumar72% | — | Downgrade | → Sell | Get Alert |
| 06/16/2016 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | -1.81% | Madhu Kumar72% | $3.25 → $3.25 | Upgrade | Sell → Neutral | Get Alert |
| 06/07/2016 | RGLS | Buy Now | Regulus Therapeutics | $1.40 | 1328.57% | Madhu Kumar72% | $1800 → $2400 | Maintains | Buy | Get Alert |
| 05/16/2016 | ABUS | Buy Now | Arbutus Biopharma | $3.31 | -1.81% | Madhu Kumar72% | → $3.25 | Initiates | → Sell | Get Alert |
| 04/13/2016 | RGLS | Buy Now | Regulus Therapeutics | $1.40 | 971.43% | Madhu Kumar72% | → $1800 | Initiates | → Buy | Get Alert |
